Ontology highlight
ABSTRACT: Summary background
Gene-based warfarin dosing algorithms have largely been developed in homogeneous populations, and their generalizability has not been established.Objectives
We sought to assess the performance of published algorithms in a racially diverse and multiethnic sample, and determine if additional clinical variables or genetic variants associated with dose could enhance algorithm performance.Patients and methods
In 145 compliant patients on warfarin with a goal international normalized ratio (INR) of 2-3, stable, therapeutic doses were compared with predicted doses using 12 reported algorithms that incorporated CYP2C9 and VKORC1 variants. Additional covariates tested with each model included race, concurrent medications, medications known to interact with
SUBMITTER: Lubitz SA
PROVIDER: S-EPMC4441275 | biostudies-literature | 2010 May
REPOSITORIES: biostudies-literature